Key result
Imipramine reversibly inhibits neuronal M-type K+ current in rat sympathetic neurons with ~7 microM IC50.
Why the study?
The effects of the antidepressant imipramine on the neuronal M-type K+ current (IK(M)) were not fully characterized.
Imipramine inhibits the M-type K+ current in rat sympathetic neurons via a voltage-independent mechanism, with the neutral form of the drug likely binding more efficiently.
Answers are grounded in this paper and cite their sources.
May alter sympathetic neuronal excitability; leaves open relevance to imipramine's clinical effects in humans.
This study aimed to assess the effects of the antidepressant drug imipramine (IMI) on the neuronal M-type K+ current (IK(M)). We show that IMI reversibly reduces IK(M) with an IC50 of 7 microM. The V0.5 and slope factor of the steady state activation curve remained unchanged after IMI, indicating a mode of action that is voltage insensitive for blocking the M-channel. Patch pipette application of IMI elicits same inhibitory response suggesting a binding site on the M-channel accessible from both sides of the cell membrane. Accordingly, the inhibitory effect of IMI is larger by rising external pH near to the pKa of the drug. Therefore, we propose that a neutral form of IMI binds more efficiently to M-channels to exert its inhibitory action by a voltage-independent mechanism.
No takes yet. Share an insight, caveat, or question.
Cuellar-Quintero et al. (2001) studied this question. Imipramine was evaluated on M-type K+ current (IK(M)) inhibition (IC50 7 microM). Imipramine reversibly inhibits the neuronal M-type K+ current in rat sympathetic neurons with an IC50 of 7 microM via a voltage-independent mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: